By inhibiting TrxR1 activity, BBSKE combined with oxaliplatin markedly induced the production of ROS, activated p38 and JNK signaling pathways, and eventually induced apoptosis of gastric cancer cells (Fig. 8). The gene discussed is TXNRD1; the disease is gastric cancer.